Characteristic | Patients with IRD (n = 170) | Patients without IRD (n = 996) | P-value |
---|---|---|---|
Age(years),mean ± SD | 33.9 ± 7.7 | 36.4 ± 9.5 | 0.001 |
Body weight (kg), mean ± SD | 48.5 ± 7.3 | 50.7 ± 15.5 | 0.13 |
CD4+ (cells/μl), mean ± SD | 84 ± 57.8 | 116 ± 69.4 | <0.001 |
WBC(cells/μl),mean ± SD | 4246 ± 1948 | 4814 ± 1729 | <0.001 |
HAART regimens (%) | |||
Lamivudine/Stavudine/Efavirenz | 31.7 | 34.4 | 0.50 |
Lamivudine/Stavudine/Nevirapine | 27.1 | 22.7 | 0.21 |
Zidovudine/Lamivudine and Efavirenz | 21.8 | 22.1 | 0.92 |
Zidovudine/Lamivudine/Nevirapine | 19.4 | 20.8 | 0.68 |
Marital status (%) | |||
Single | 28.8 | 31.9 | 0.42 |
Married | 47.0 | 49.1 | 0.62 |
Divorced | 11.8 | 9.2 | 0.30 |
Widowed | 12.4 | 9.7 | 0.30 |
Gender (%) | |||
Male | 49.4 | 43.9 | 0.18 |
Female | 50.6 | 56.1 | |
Site of TB (%) | |||
PTB | 29.4 | 33.7 | 0.27 |
EPTB | 52.4 | 5.8 | <0.001 |
DTB | 4.7 | 3.9 | 0.63 |